Cargando…

A Case Study of Pharmaceutical Pricing in China: Setting the Price for Off-Patent Originators

This article aims to define a value-based approach to pricing and reimbursement for off-patent originators using a multiple criteria decision analysis (MCDA) approach centered on a systematic analysis of current pricing and reimbursement policies in China. A drug price policy review was combined wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Shanlian, Zhang, Yabing, He, Jiangjiang, Du, Lixia, Xu, Mingfei, Xie, Chunyan, Peng, Ying, Wang, Linan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2015
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4519586/ https://www.ncbi.nlm.nih.gov/pubmed/26091710 http://dx.doi.org/10.1007/s40258-014-0150-5

Ejemplares similares

Dynamics of price competition in Italian pharmaceutical off-patent market
por: Perna, Serena, et al.
Publicado: (2022)

Off-patent drugs at brand-name prices: a puzzle for policymakers
por: Tallapragada, Naren P.
Publicado: (2016)

Paying for On-Patent Pharmaceuticals: Limit Prices and the Emerging Role of a Pay for Outcomes Approach
por: Fuller, Richard L., et al.
Publicado: (2016)

Impact of Generic Price Linkage System and Reference Price System on prices of pharmaceuticals – comparison of Austria and Finland
por: Martikainen, Jaana E, et al.
Publicado: (2015)

Drug pricing reform in China: analysis of piloted approaches and potential impact of the reform
por: Chen, Yixi, et al.
Publicado: (2016)

Effects of Volume-Price Contracts on Pharmaceutical Prices: A Retrospective Comparative Study of Public Hospitals in Hubei of China
por: Li, Zhuoxian, et al.
Publicado: (2021)

Identifying Key Benefits in European Off-Patent Biologics and Biosimilar Markets: It is Not Only About Price!
por: Dutta, Binita, et al.
Publicado: (2019)

Price indexes for pharmaceuticals used by the elderly
por: Thomas, Joseph, et al.
Publicado: (1992)

The Promise of Specialty Pharmaceuticals: Are They Worth the Price?
por: Sullivan, Sean D.
Publicado: (2008)

What condition leads to an unreasonable pharmaceutical price? Impact research on the effect of medical service provision on pharmaceutical price regulation based on fuss-set QCA
por: Fang, Lingzhi Brian, et al.
Publicado: (2023)

The price of innovation - the role of drug pricing in financing pharmaceutical innovation. A conceptual framework
por: Moreno, Santiago G., et al.
Publicado: (2019)

China and Weapons of Mass Production: The "China Price" Is the "Cheating Price
por: Navarro, Peter
Publicado: (2010)

Marketing before patenting: implications for price controls in Canada
por: Lexchin, Joel
Publicado: (2010)

Characteristics and Price Increases Among Sole-Source, Off-Patent Drugs in the United States, 2008 to 2018
por: Alpern, Jonathan D., et al.
Publicado: (2020)

Price wars and price collusion in China's airline markets
por: Zhang, Yahua, et al.
Publicado: (2011)

Pharmaceutical pricing and reimbursement policies: perspectives for the future
por: Gray, Andrew L
Publicado: (2015)

Challenges and opportunities for pharmaceutical pricing and reimbursement policies
por: Vogler, Sabine, et al.
Publicado: (2015)

Orphan Drug Pricing: An Original Exponential Model Relating Price to the Number of Patients
por: Messori, Andrea
Publicado: (2016)

The Influence of the Inconsistent Color Presentation of the Original Price and Sale Price on Purchase Likelihood
por: Liang, Shichang, et al.
Publicado: (2021)

Association between medicine Price declaration by pharmaceutical industries and retail prices in Malaysia’s private healthcare sector
por: Ahmad, Nur Sufiza, et al.
Publicado: (2019)

Does price disclosure in pharmaceutical advertising result in price transparency? Evidence from a randomized experiment
por: Hollin, Ilene L., et al.
Publicado: (2022)

Collective pharmaceutical procurement in China may have unintended consequences in supply and pricing
por: Jiang, Shan, et al.
Publicado: (2020)

Trends in List Prices, Net Prices, and Discounts for Originator Biologics Facing Biosimilar Competition
por: San-Juan-Rodriguez, Alvaro, et al.
Publicado: (2019)

Norwegian Physicians’ Knowledge of the Prices of Pharmaceuticals: A Survey
por: Eriksen, Ida Iren, et al.
Publicado: (2013)

Factors Impacting Pharmaceutical Prices and Affordability: Narrative Review
por: Lee, Kah Seng, et al.
Publicado: (2020)

Prices and Clinical Benefit of National Price-Negotiated Anticancer Medicines in China
por: Zhang, Yichen, et al.
Publicado: (2022)

Relationship between pharmaceutical pricing strategies with price, availability, and affordability of cardiovascular disease medicines: surveys in Qatar and Lebanon
por: Abdel Rida, N., et al.
Publicado: (2019)

The Impact of Patent Expiry on Drug Prices: A Systematic Literature Review
por: Vondeling, Gerard T., et al.
Publicado: (2018)

The impact of patent expiry on drug prices: insights from the Dutch market
por: van der Schans, Simon, et al.
Publicado: (2020)

Vaccine pricing strategies in China
por: Zhang, Haonan, et al.
Publicado: (2023)

A Comparison of Pharmaceutical Budget Impact Analysis (BIA) Recommendations Amongst the Canadian Patented Medicine Prices Review Board (PMPRB), Public and Private Payers
por: Foroutan, Naghmeh, et al.
Publicado: (2019)

When Customers Help Set Prices
por: Mak, Vincent
Publicado: (2014)

Reimbursement of pharmaceuticals: reference pricing versus health technology assessment
por: Drummond, Michael, et al.
Publicado: (2010)

PHARMACEUTICAL PRICING IN EMERGING MARKETS: EFFECTS OF INCOME, COMPETITION, AND PROCUREMENT
por: Danzon, Patricia M, et al.
Publicado: (2015)

Pharmaceutical Pricing Policy in Greece: Toward a Different Path
por: Souliotis, Kyriakos, et al.
Publicado: (2016)

Government pharmaceutical pricing strategies in the Asia-Pacific region: an overview
por: Verghese, Naina R., et al.
Publicado: (2019)

The impact of external reference pricing on pharmaceutical costs and market dynamics
por: Voehler, Dominic, et al.
Publicado: (2023)

The impacts and unintended consequences of the nationwide pricing reform for drugs and medical services in the urban public hospitals in China
por: Zhang, Xiaoxi, et al.
Publicado: (2020)

Innovative price-setting approaches to high-value products: A pricing method for agribusiness farmers
por: Naruetharadhol, Phaninee, et al.
Publicado: (2022)

The patent buyout price for human papilloma virus (HPV) vaccine and the ratio of R&D costs to the patent value
por: Songane, Mario, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_b3sp0n6kid8jk3t769d0dlo1ng